GCM
HGEN

Graham Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

Graham Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-36,940
Closed -$65K – 1386
2022
Q2 		$65K Buy
+36,940
New +$82.9K ﹤0.01% 968

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Graham Capital Management's HGEN Position: Q3 2022 in Review

Graham Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 36,940 shares — an estimated $65K sold.

Graham Capital Management first reported a position in HGEN in Q2 2022 and held it in 1 quarter. The position peaked at $65K in Q2 2022. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Graham Capital Management reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Graham Capital Management sold 36,940 HUMANIGEN, INC. shares in Q3 2022, an estimated $65K.
  • Graham Capital Management first reported a position in HUMANIGEN, INC. in Q2 2022 and held it in 1 quarter.
  • Graham Capital Management's HUMANIGEN, INC. position peaked at $65K in Q2 2022.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Graham Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.